To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UBE3BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
549 supporting clones for gene UBE3B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_130466.2   UBE3B.a 1 to 5728 2 to 5729 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5729/5729
(100 %)
0 diff
(100 %id)
BE246961 leukopheresis UBE3B.a 1 to 455 2 to 455   tiling clone,   455/461
(98 %)
5 diff
(99.0 %id)
DR001994 fetal brain UBE3B.a 3 to 656 1 to 654       654/654
(100 %)
4 diff
(99.4 %id)
TI_2194696118   UBE3B.a 6 to 1136 76 to 1199       1124/1289
(87 %)
69 diff
(94.7 %id)
TI_2194698825   UBE3B.a 6 to 1099 82 to 1171       1088/1318
(82 %)
27 diff
(98.0 %id)
TI_2194699182   UBE3B.a 6 to 1140 76 to 1199       1124/1300
(86 %)
19 diff
(98.6 %id)
CX758213 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE3B.a 8 to 768 28 to 783     Submitted on the opposite strand 756/824
(91 %)
25 diff
(97.0 %id)
BC144684 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones UBE3B.a 13 to 4591 1 to 4579 Q638* tiling clone,   4579/4579
(100 %)
1 diff
(100.0 %id)
CX756858 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE3B.a 14 to 617 1 to 604     Submitted on the opposite strand 604/604
(100 %)
0 diff
(100 %id)
CX760231 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE3B.a 15 to 583 1 to 570     Submitted on the opposite strand 570/752
(75 %)
6 diff
(99.3 %id)
BX404957 B cells (Ramos cell line) UBE3B.a 16 to 879 1 to 862       862/866
(99 %)
3 diff
(99.7 %id)
BX464577 B cells (Ramos cell line) UBE3B.a 16 to 813 1 to 798       798/798
(100 %)
1 diff
(99.9 %id)
BG281394 melanotic melanoma, skin UBE3B.a 17 to 807 1 to 788       788/791
(99 %)
14 diff
(98.3 %id)
BG478053 melanotic melanoma, skin UBE3B.a 17 to 804 1 to 791   available from MGC,   791/795
(99 %)
6 diff
(99.3 %id)
BG490557 large cell carcinoma, lung UBE3B.a 18 to 636 1 to 616       616/616
(100 %)
7 diff
(98.9 %id)
BI767741 pooled lung and spleen UBE3B.a 18 to 582 1 to 580       578/1063
(54 %)
36 diff
(96.7 %id)
TI_57183749   UBE3B.a 18 to 582 27 to 606       578/1089
(53 %)
14 diff
(98.8 %id)
AF251046   UBE3B.a 19 to 5728 1 to 5707 R346X tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5707/5707
(100 %)
3 diff
(100.0 %id)
BM041089 Kidney, Wilms' tumor, cell line UBE3B.a 20 to 581 11 to 580       570/790
(72 %)
17 diff
(97.9 %id)
BX106747 liver and spleen UBE3B.a 21 to 747 1 to 727       727/727
(100 %)
1 diff
(99.9 %id)
T49897 placenta UBE3B.a 21 to 397 1 to 378       378/378
(100 %)
6 diff
(98.5 %id)
BX383241   UBE3B.a 30 to 885 1 to 851       851/851
(100 %)
22 diff
(97.5 %id)
BE386514 melanotic melanoma, skin UBE3B.a 37 to 745 1 to 706       706/706
(100 %)
12 diff
(98.4 %id)
BF849567 lung_normal UBE3B.a 58 to 301 1 to 243       243/243
(100 %)
8 diff
(96.8 %id)
BE727364 melanotic melanoma, skin UBE3B.a 60 to 820 1 to 768       765/1143
(66 %)
21 diff
(98.2 %id)
CN423057 embryonic stem cells, DMSO-treated H9 cellline UBE3B.a 105 to 618 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BC141880 PCR rescued clones UBE3B.a 111 to 4890 1 to 4781 R346Q     4781/4781
(100 %)
4 diff
(100.0 %id)
DR001624 fetal brain UBE3B.a 315 to 945 1 to 631       631/631
(100 %)
6 diff
(99.1 %id)
AL525372 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized UBE3B.a 341 to 1238 1 to 900   fully sequenced,   900/900
(100 %)
10 diff
(98.9 %id)
BM541738 leiomyosarcoma, uterus UBE3B.a 383 to 1233 1 to 864       862/1105
(78 %)
15 diff
(98.7 %id)
C04105 heart UBE3B.a 406 to 760 1 to 364       364/368
(98 %)
11 diff
(97.1 %id)
AL525331 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized UBE3B.a 854 to 1224 422 to 51   fully sequenced,   372/422
(88 %)
7 diff
(98.4 %id)
DB069113 testis UBE3B.b 1 to 542 2 to 543   tiling clone, capped   542/542
(100 %)
1 diff
(99.9 %id)
DB081482 testis UBE3B.b 9 to 461 2 to 454   capped   453/453
(100 %)
0 diff
(100 %id)
DA771082 brain UBE3B.b 222 to 810 2 to 590   capped   589/589
(100 %)
1 diff
(99.9 %id)
DB198968 trachea UBE3B.b 224 to 790 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA453320 tongue, tumor tissue UBE3B.b 225 to 787 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA048483   UBE3B.b 227 to 781 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA096454 cerebellum UBE3B.b 227 to 751 2 to 528   capped   527/527
(100 %)
2 diff
(99.7 %id)
DA281722 corpus callosum UBE3B.b 227 to 737 2 to 513   capped   512/512
(100 %)
2 diff
(99.7 %id)
DA502946 brain UBE3B.b 227 to 666 2 to 442   capped   441/441
(100 %)
2 diff
(99.6 %id)
DB084231 testis UBE3B.b 227 to 804 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DB084985 testis UBE3B.b 227 to 788 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB085063 testis UBE3B.b 227 to 783 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
DA489693 brain UBE3B.b 229 to 797 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BX537403 human endometrium carcinoma cell line UBE3B.b 231 to 5615 1 to 5383 E151V R346Q I907V Y942H F1018S tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5383/5383
(100 %)
14 diff
(99.8 %id)
NM_183415.1   UBE3B.b 232 to 5615 1 to 5384 exact RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 5384/5384
(100 %)
0 diff
(100 %id)
DA022182   UBE3B.b 233 to 791 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA144928 amygdala UBE3B.b 233 to 787 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA583832 lung UBE3B.b 233 to 826 2 to 595   capped   594/594
(100 %)
1 diff
(99.9 %id)
DB086760 testis UBE3B.b 233 to 788 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DA873672 Prostate UBE3B.b 234 to 797 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB033732 testis UBE3B.b 234 to 811 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA886144   UBE3B.b 237 to 804 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB243021 stomach, tumor tissue UBE3B.b 237 to 810 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
TI_2016725133   UBE3B.b 238 to 1392 78 to 1216       1141/1276
(89 %)
32 diff
(97.5 %id)
TI_2016725621   UBE3B.b 238 to 1095 863 to 7       857/1269
(67 %)
4 diff
(99.7 %id)
TI_2016727183   UBE3B.b 238 to 1291 82 to 1129       1050/1324
(79 %)
28 diff
(97.9 %id)
BM921244 pooled brain, lung, testis UBE3B.b 238 to 1091 12 to 871       860/1057
(81 %)
22 diff
(98.0 %id)
DB090280 testis UBE3B.b 240 to 751 2 to 513   capped   512/512
(100 %)
0 diff
(100 %id)
BI832072 brain, medulla UBE3B.b 242 to 1028 1 to 791   available from MGC,   789/796
(99 %)
18 diff
(97.8 %id)
TI_57173183   UBE3B.b 242 to 1028 1 to 791       789/796
(99 %)
18 diff
(97.8 %id)
BC032301 Brain, adult medulla UBE3B.b 243 to 3567 1 to 3325   tiling clone, available from MGC,   3325/3325
(100 %)
0 diff
(100 %id)
BC150637 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones UBE3B.b 245 to 4485 1 to 4241 L310P tiling clone,   4241/4241
(100 %)
1 diff
(100.0 %id)
DR000744 fetal brain UBE3B.b 245 to 883 1 to 642       642/642
(100 %)
8 diff
(98.8 %id)
BX384077   UBE3B.b 250 to 1303 1 to 1053       1053/1057
(99 %)
3 diff
(99.8 %id)
BF030034 hypernephroma, Kidney UBE3B.b 255 to 936 1 to 684       682/748
(91 %)
38 diff
(95.0 %id)
DB207244 trachea UBE3B.b 258 to 882 2 to 627   capped   626/627
(99 %)
4 diff
(99.4 %id)
BG026219 Bone, osteosarcoma, cell line UBE3B.b 431 to 1035 15 to 619   available from MGC,   605/896
(67 %)
13 diff
(98.6 %id)
BE930522 placenta_normal UBE3B.b 450 to 651 1 to 203       203/206
(98 %)
6 diff
(97.1 %id)
TI_2194697135   UBE3B.b 466 to 1565 1111 to 15       1097/1253
(87 %)
6 diff
(99.6 %id)
BF831023 head_neck UBE3B.b 466 to 741 78 to 354       277/354
(78 %)
7 diff
(98.1 %id)
AW364878 denis_drash UBE3B.b 469 to 932 464 to 1       464/466
(99 %)
3 diff
(99.4 %id)
AF130072 Liver UBE3B.b 484 to 3568 1 to 3085       3085/3085
(100 %)
4 diff
(99.9 %id)
AI174745 Liver UBE3B.b 484 to 860 1 to 377       377/377
(100 %)
1 diff
(99.8 %id)
DA055450 cerebellum UBE3B.b 486 to 1044 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
TI_1948233387   UBE3B.b 489 to 788 143 to 442       300/328
(91 %)
6 diff
(98.2 %id)
TI_1948233545   UBE3B.b 489 to 1035 133 to 681       547/1327
(41 %)
13 diff
(99.1 %id)
EL736643 mixed UBE3B.b 490 to 936 1 to 447       447/449
(99 %)
6 diff
(98.7 %id)
BE241448 leukopheresis UBE3B.b 516 to 862 1 to 347       347/347
(100 %)
2 diff
(99.5 %id)
BE242220 leukopheresis UBE3B.b 516 to 853 1 to 338       338/338
(100 %)
0 diff
(100 %id)
BM144840 leukopheresis UBE3B.b 516 to 995 1 to 480       480/480
(100 %)
0 diff
(100 %id)
BM149630 leukopheresis UBE3B.b 516 to 1090 1 to 575       575/575
(100 %)
1 diff
(99.9 %id)
BE243716 leukopheresis UBE3B.b 516 to 849 1 to 334       334/334
(100 %)
0 diff
(100 %id)
BE243709 leukopheresis UBE3B.b 516 to 767 1 to 252       252/252
(100 %)
2 diff
(99.3 %id)
BF905771 marrow UBE3B.b 518 to 802 1 to 285       285/285
(100 %)
9 diff
(96.9 %id)
BQ327930 kidney_tumor UBE3B.b 533 to 1116 20 to 599       580/599
(96 %)
7 diff
(98.9 %id)
BQ327935 kidney_tumor UBE3B.b 533 to 1101 21 to 588       568/588
(96 %)
9 diff
(98.5 %id)
BQ328006 kidney_tumor UBE3B.b 536 to 1107 6 to 577       572/577
(99 %)
13 diff
(97.8 %id)
BQ327989 kidney_tumor UBE3B.b 543 to 1116 34 to 609       576/647
(89 %)
8 diff
(98.8 %id)
BQ300573 bladder_tumor UBE3B.b 550 to 1009 1 to 461       461/461
(100 %)
1 diff
(99.8 %id)
TI_2194698584   UBE3B.b 552 to 1750 8 to 1197       1190/1287
(92 %)
23 diff
(98.3 %id)
U47346 eye, osteosarcoma UBE3B.b 577 to 822 1 to 246       246/246
(100 %)
2 diff
(99.2 %id)
FN070340 breast carcinoma UBE3B.b 666 to 761 97 to 1     Submitted on the opposite strand 97/98
(98 %)
1 diff
(99.0 %id)
BQ327808 kidney_tumor UBE3B.b 711 to 1208 497 to 4       496/575
(86 %)
10 diff
(98.3 %id)
TI_2016725619   UBE3B.b 735 to 1924 1184 to 9       1127/1243
(90 %)
17 diff
(98.7 %id)
BQ327759 kidney_tumor UBE3B.b 746 to 932 185 to 1       185/185
(100 %)
11 diff
(94.1 %id)
DA502354 brain UBE3B.b 746 to 1311 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
TI_2194697136   UBE3B.b 770 to 1929 1154 to 7       1148/1260
(91 %)
14 diff
(98.9 %id)
R10231 liver and spleen UBE3B.b 770 to 1079 1 to 313       311/313
(99 %)
3 diff
(99.1 %id)
CB990646 Human Placenta, placenta UBE3B.b 832 to 1476 27 to 682       656/784
(83 %)
32 diff
(96.0 %id)
TI_2194697098   UBE3B.b 853 to 2025 11 to 1171       1161/1277
(90 %)
22 diff
(98.3 %id)
BQ327990 kidney_tumor UBE3B.b 934 to 1498 565 to 3       563/608
(92 %)
4 diff
(99.4 %id)
BQ327987 kidney_tumor UBE3B.b 956 to 1417 462 to 1       462/462
(100 %)
3 diff
(99.4 %id)
BQ693963 adipose UBE3B.b 990 to 1474 1 to 484       484/484
(100 %)
3 diff
(99.4 %id)
BQ327922 kidney_tumor UBE3B.b 1104 to 1264 1 to 161       161/161
(100 %)
10 diff
(93.8 %id)
DA323264 hippocampus UBE3B.b 1123 to 1682 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
TI_2194697099   UBE3B.b 1307 to 2426 1126 to 12       1115/1258
(88 %)
9 diff
(99.3 %id)
DA314029 hippocampus UBE3B.b 1363 to 1916 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
DA405924 thalamus UBE3B.b 1365 to 2035 2 to 673   capped   672/672
(100 %)
2 diff
(99.8 %id)
DA343501 substantia nigra UBE3B.b 1368 to 1947 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
BE780480 eye, retinoblastoma UBE3B.b 1378 to 2080 1 to 705       705/891
(79 %)
41 diff
(95.4 %id)
DA237569 brain UBE3B.b 1383 to 1961 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DA755450   UBE3B.b 1383 to 1908 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
DB065560 testis UBE3B.b 1386 to 1956 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
BU663501 blood UBE3B.b 1402 to 1920 1 to 519       519/519
(100 %)
4 diff
(99.3 %id)
R10738 liver and spleen UBE3B.b 1509 to 1720 212 to 1       212/212
(100 %)
1 diff
(99.6 %id)
BF981648 duodenal adenocarcinoma, cell line, small intestine UBE3B.b 1542 to 2155 53 to 666       614/666
(92 %)
15 diff
(97.8 %id)
BQ879394 dorsal root ganglia UBE3B.b 1627 to 2503 1 to 881       881/888
(99 %)
14 diff
(98.5 %id)
CX872648 embryonic stem UBE3B.b 1680 to 2477 1 to 798       798/798
(100 %)
3 diff
(99.7 %id)
TI_2194697140   UBE3B.b 1817 to 2976 15 to 1162       1153/1269
(90 %)
19 diff
(98.6 %id)
DA628773 Kidney UBE3B.b 1820 to 2357 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA119904 cerebellum UBE3B.b 1829 to 2390 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
CD653496 Embryonic Stem cells UBE3B.b 1850 to 2565 1 to 711       711/797
(89 %)
7 diff
(99.2 %id)
BX375002 Neuroblastoma Cot 25-normalized UBE3B.b 1937 to 2978 1 to 1030       1030/1030
(100 %)
16 diff
(98.5 %id)
CV809547 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE3B.b 1989 to 2795 1 to 808       808/811
(99 %)
10 diff
(98.8 %id)
AW504961 lymph UBE3B.b 2058 to 2482 8 to 432       425/432
(98 %)
11 diff
(97.5 %id)
BQ434068 melanotic melanoma, skin UBE3B.b 2058 to 2798 1 to 747       747/811
(92 %)
11 diff
(98.7 %id)
TI_154161306   UBE3B.b 2058 to 2566 69 to 576       508/566
(89 %)
15 diff
(97.4 %id)
AW503136 lymph UBE3B.b 2067 to 2608 7 to 548       542/548
(98 %)
6 diff
(99.0 %id)
TI_154158898   UBE3B.b 2067 to 2734 89 to 755       667/667
(100 %)
10 diff
(98.6 %id)
CA488803   UBE3B.b 2110 to 2971 1 to 867       867/868
(99 %)
9 diff
(99.0 %id)
DB228070 trachea UBE3B.b 2144 to 2724 2 to 582   capped   581/581
(100 %)
4 diff
(99.4 %id)
CA489197   UBE3B.b 2171 to 3044 28 to 909       880/909
(96 %)
14 diff
(98.5 %id)
TI_57201705   UBE3B.b 2171 to 2854 31 to 713       683/722
(94 %)
8 diff
(98.9 %id)
BI821961 pooled brain, lung, testis UBE3B.b 2172 to 2854 1 to 682       682/691
(98 %)
2 diff
(99.8 %id)
BC020348 Cervix, carcinoma UBE3B.b 2182 to 3576 1 to 1395   available from MGC,   1395/1395
(100 %)
0 diff
(100 %id)
BE545355 cervical carcinoma cell line, cervix UBE3B.b 2203 to 2742 1 to 551   available from MGC,   551/557
(98 %)
20 diff
(96.5 %id)
DB027438 testis UBE3B.b 2226 to 2810 2 to 586   capped   585/585
(100 %)
1 diff
(99.9 %id)
CK000452 mixed UBE3B.b 2229 to 2937 32 to 735       704/797
(88 %)
24 diff
(97.0 %id)
BE543395 cervical carcinoma cell line, cervix UBE3B.b 2255 to 2942 1 to 689       689/690
(99 %)
15 diff
(97.9 %id)
TI_2194697095   UBE3B.b 2272 to 3383 1110 to 6       1105/1225
(90 %)
10 diff
(99.2 %id)
CU456817 epidermis UBE3B.b 2300 to 2389 13 to 102       90/109
(82 %)
14 diff
(87.2 %id)
BQ062792 lymph, lymphoma, cell line UBE3B.b 2306 to 3116 25 to 834       810/1033
(78 %)
16 diff
(98.5 %id)
BQ061913 lymph, lymphoma, cell line UBE3B.b 2316 to 3246 1 to 940       940/1012
(92 %)
21 diff
(98.0 %id)
TI_2016725591   UBE3B.b 2343 to 3386 1044 to 5       1040/1219
(85 %)
4 diff
(99.7 %id)
TI_2194697139   UBE3B.b 2395 to 3452 5 to 1064       1060/1267
(83 %)
9 diff
(99.3 %id)
BG469515 adenocarcinoma cell line, colon UBE3B.b 2461 to 2817 1 to 356       356/857
(41 %)
6 diff
(99.3 %id)
CA396226 eye, RPE/choroid UBE3B.b 2489 to 3057 1 to 569       569/570
(99 %)
6 diff
(99.0 %id)
BM150306 leukopheresis UBE3B.b 2524 to 3217 694 to 1       694/694
(100 %)
0 diff
(100 %id)
BI006569 kidney_tumor UBE3B.b 2529 to 2788 259 to 1       259/259
(100 %)
1 diff
(99.7 %id)
BM194586 leukopheresis UBE3B.b 2564 to 3217 653 to 1       653/663
(98 %)
3 diff
(99.6 %id)
BG528042 lung, mucoepidermoid carcinoma UBE3B.b 2585 to 3178 1 to 598       598/927
(64 %)
10 diff
(99.0 %id)
BU157756 ductal carcinoma, cell line, Pancreas UBE3B.b 2624 to 3413 1 to 800       800/902
(88 %)
12 diff
(98.7 %id)
BF092157 testis_normal UBE3B.b 2687 to 2981 296 to 3       294/297
(98 %)
6 diff
(98.0 %id)
BF092191 testis_normal UBE3B.b 2687 to 2971 291 to 8       284/292
(97 %)
9 diff
(97.0 %id)
TI_2016725589   UBE3B.b 2737 to 3898 1158 to 11       1148/1255
(91 %)
18 diff
(98.6 %id)
BX390156 Neuroblastoma Cot 25-normalized UBE3B.b 2740 to 3296 1 to 558       558/558
(100 %)
68 diff
(87.9 %id)
BE243830 leukopheresis UBE3B.b 2747 to 3217 474 to 1       474/476
(99 %)
10 diff
(97.9 %id)
DA629306 Kidney UBE3B.b 2766 to 3338 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF830009 head_normal UBE3B.b 2771 to 3411 29 to 669       641/705
(90 %)
10 diff
(98.6 %id)
BM146240 leukopheresis UBE3B.b 2771 to 3217 447 to 1       447/447
(100 %)
0 diff
(100 %id)
TI_2194697138   UBE3B.b 2820 to 3915 14 to 1101       1088/1234
(88 %)
15 diff
(98.8 %id)
AW024608 Kidney UBE3B.b 2842 to 3558 717 to 1       717/789
(90 %)
20 diff
(97.5 %id)
TI_154136526   UBE3B.b 2852 to 3580 753 to 21       733/1243
(58 %)
36 diff
(97.2 %id)
BM829762 stomach UBE3B.b 2857 to 2983 1 to 127       127/127
(100 %)
2 diff
(98.5 %id)
BM821254 stomach UBE3B.b 2859 to 3277 1 to 419       419/419
(100 %)
0 diff
(100 %id)
TI_2194697101   UBE3B.b 2866 to 3898 1034 to 9       1026/1242
(82 %)
6 diff
(99.6 %id)
DA371251 thalamus UBE3B.b 2868 to 3398 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
BQ614638 insulinoma, Pancreas UBE3B.b 2871 to 3305 8 to 442       435/442
(98 %)
6 diff
(98.7 %id)
BE241844 leukopheresis UBE3B.b 2872 to 3217 345 to 1       345/345
(100 %)
8 diff
(97.7 %id)
BM194222 leukopheresis UBE3B.b 2872 to 3217 347 to 1       347/347
(100 %)
7 diff
(98.0 %id)
BM146294 leukopheresis UBE3B.b 2890 to 3217 328 to 1       328/329
(99 %)
2 diff
(99.4 %id)
AA633227 colon, colon tumor RER+ UBE3B.b 2935 to 3480 545 to 1       545/545
(100 %)
3 diff
(99.5 %id)
AI885033 anaplastic oligodendroglioma, brain UBE3B.b 2938 to 3580 643 to 1       643/643
(100 %)
23 diff
(96.5 %id)
AW182483 pooled UBE3B.b 2938 to 3558 621 to 1       621/621
(100 %)
3 diff
(99.6 %id)
AI004181 breast UBE3B.b 2939 to 3550 613 to 2       612/614
(99 %)
4 diff
(99.4 %id)
BE247617 leukopheresis UBE3B.b 2973 to 3217 246 to 1       246/250
(98 %)
3 diff
(98.8 %id)
AI684367 B-cell, chronic lymphotic leukemia UBE3B.b 2990 to 3558 569 to 1       569/570
(99 %)
2 diff
(99.7 %id)
AI623729 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE3B.b 3017 to 3576 561 to 2       560/562
(99 %)
1 diff
(99.9 %id)
BM927617 lymph, lymphoma, cell line UBE3B.b 3021 to 3979 1 to 972       972/1073
(90 %)
21 diff
(98.1 %id)
BQ061239 lymph, lymphoma, cell line UBE3B.b 3021 to 3957 1 to 945       945/1004
(94 %)
30 diff
(97.1 %id)
BQ064867 lymph, lymphoma, cell line UBE3B.b 3021 to 3925 1 to 923       923/996
(92 %)
34 diff
(96.6 %id)
AA333194 Embryo, 8 weeks UBE3B.b 3029 to 3392 1 to 367       367/367
(100 %)
3 diff
(99.2 %id)
BF195084 fibrotheoma, ovary UBE3B.b 3055 to 3576 522 to 1       522/561
(93 %)
21 diff
(96.3 %id)
AI672779 colon, colonic mucosa from 3 patients with Crohn'sdisease UBE3B.b 3066 to 3576 509 to 1       509/509
(100 %)
3 diff
(99.5 %id)
AA278883 germinal center B cell UBE3B.b 3070 to 3576 504 to 1       504/504
(100 %)
4 diff
(99.3 %id)
AA857731 adenocarcinoma, colon UBE3B.b 3070 to 3572 502 to 4       499/502
(99 %)
5 diff
(99.1 %id)
AA935835 2 pooled tumors (clear cell type), Kidney UBE3B.b 3070 to 3164 97 to 3       95/97
(97 %)
5 diff
(94.9 %id)
AI356502 B-cell, chronic lymphotic leukemia UBE3B.b 3070 to 3461 391 to 1       391/391
(100 %)
2 diff
(99.5 %id)
AA993988 pooled UBE3B.b 3072 to 3547 493 to 19       475/493
(96 %)
4 diff
(99.2 %id)
AI161249 brain, glioblastoma (pooled) UBE3B.b 3074 to 3576 503 to 1       503/503
(100 %)
0 diff
(100 %id)
AA865731 pooled germ cell tumors UBE3B.b 3082 to 3543 461 to 1       461/464
(99 %)
2 diff
(99.6 %id)
DA291991 hippocampus UBE3B.b 3100 to 3661 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA142930 alzheimer cortex UBE3B.b 3113 to 3673 2 to 562   capped   561/562
(99 %)
1 diff
(99.9 %id)
BE244027 leukopheresis UBE3B.b 3113 to 3217 105 to 1       105/105
(100 %)
0 diff
(100 %id)
BI018369 marrow UBE3B.b 3117 to 3453 9 to 345       337/345
(97 %)
1 diff
(99.8 %id)
BE264361 lung, small cell carcinoma UBE3B.b 3167 to 3812 1 to 644       644/644
(100 %)
3 diff
(99.6 %id)
BM977761 lung, Primary Lung Cystic Fibrosis EpithelialCells UBE3B.b 3167 to 3935 782 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 764/764
(100 %)
5 diff
(99.4 %id)
DA767306 tongue UBE3B.b 3169 to 3738 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
R06484 liver and spleen UBE3B.b 3173 to 3493 1 to 327       327/401
(81 %)
12 diff
(97.1 %id)
W90285 liver and spleen UBE3B.b 3173 to 3608 1 to 436   fully sequenced,   436/436
(100 %)
3 diff
(99.4 %id)
BQ187392 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE3B.b 3178 to 3568 1 to 391       391/391
(100 %)
0 diff
(100 %id)
TI_151734376   UBE3B.b 3178 to 3580 439 to 37       403/1029
(39 %)
0 diff
(100 %id)
BI193530 epithelioid carcinoma cell line, Pancreas UBE3B.b 3183 to 3744 1 to 566       566/908
(62 %)
42 diff
(95.4 %id)
AI560297 anaplastic oligodendroglioma, brain UBE3B.b 3189 to 3558 371 to 1       371/373
(99 %)
2 diff
(99.5 %id)
DA141830 alzheimer cortex UBE3B.b 3206 to 3739 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
AI940363 colon UBE3B.b 3237 to 3477 27 to 267       241/267
(90 %)
6 diff
(97.8 %id)
TI_2194697137   UBE3B.b 3252 to 4389 1 to 1129       1129/1237
(91 %)
18 diff
(98.6 %id)
AI262347 adenocarcinoma, colon UBE3B.b 3254 to 3558 305 to 1       305/305
(100 %)
0 diff
(100 %id)
DA013769 adrenal gland UBE3B.b 3255 to 3838 2 to 585   capped   584/584
(100 %)
1 diff
(99.9 %id)
AA780043 liver and spleen UBE3B.b 3265 to 3935 673 to 1       673/673
(100 %)
12 diff
(98.3 %id)
AA634554   UBE3B.b 3276 to 3573 298 to 3       296/298
(99 %)
0 diff
(100 %id)
BQ644882 hepatocellular carcinoma, cell line, Liver UBE3B.b 3277 to 4072 1 to 800       800/933
(85 %)
15 diff
(98.4 %id)
AA609285   UBE3B.b 3285 to 3573 288 to 3       286/288
(99 %)
0 diff
(100 %id)
BF760518 colon UBE3B.b 3295 to 3673 3 to 380       378/389
(97 %)
8 diff
(98.0 %id)
AI264287 Kidney UBE3B.b 3316 to 3576 261 to 1       261/261
(100 %)
0 diff
(100 %id)
DA579288   UBE3B.b 3317 to 3848 2 to 533   capped   532/532
(100 %)
0 diff
(100 %id)
AA992467 carcinoid, lung UBE3B.b 3317 to 3541 224 to 1       224/224
(100 %)
1 diff
(99.6 %id)
TI_2194696121   UBE3B.b 3363 to 4485 1222 to 107       1116/1277
(87 %)
18 diff
(98.6 %id)
AA682435 liver and spleen UBE3B.b 3373 to 3935 575 to 13   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 563/563
(100 %)
11 diff
(98.1 %id)
BE393480 endometrium, adenocarcinoma cell line, uterus UBE3B.b 3387 to 4065 1 to 675       675/682
(98 %)
22 diff
(96.8 %id)
DA144283 amygdala UBE3B.b 3402 to 3958 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
TI_2194699561   UBE3B.b 3413 to 4485 1162 to 107       1034/1282
(80 %)
9 diff
(99.3 %id)
EC466210 Prostate UBE3B.b 3504 to 3604 101 to 1       101/101
(100 %)
0 diff
(100 %id)
TI_1968236237   UBE3B.b 3508 to 4493 1151 to 179       973/1305
(74 %)
33 diff
(97.5 %id)
CN423058 embryonic stem cells, cell lines H1, H7, andH9 UBE3B.b 3508 to 3754 1 to 247       247/247
(100 %)
0 diff
(100 %id)
AI032464 liver and spleen UBE3B.b 3537 to 3652 115 to 1       115/115
(100 %)
4 diff
(96.6 %id)
AA789033 parathyroid gland, parathyroid tumor UBE3B.b 3569 to 3918 1 to 350     Submitted on the opposite strand 350/350
(100 %)
0 diff
(100 %id)
AA782218 parathyroid gland, parathyroid tumor UBE3B.b 3569 to 4117 1 to 546     Submitted on the opposite strand 546/546
(100 %)
5 diff
(99.1 %id)
AA781622 parathyroid gland, parathyroid tumor UBE3B.b 3569 to 3867 1 to 299     Submitted on the opposite strand 299/299
(100 %)
0 diff
(100 %id)
N75041 lung UBE3B.b 3569 to 3882 1 to 316     Submitted on the opposite strand 316/317
(99 %)
12 diff
(96.3 %id)
W78138 heart UBE3B.b 3569 to 4041 1 to 473     Submitted on the opposite strand 473/473
(100 %)
1 diff
(99.8 %id)
AA013484 eye, retina UBE3B.b 3569 to 3739 1 to 173     Submitted on the opposite strand 173/175
(98 %)
2 diff
(98.9 %id)
AA016017 eye, retina UBE3B.b 3569 to 4048 1 to 482     Submitted on the opposite strand 482/482
(100 %)
3 diff
(99.4 %id)
AA056971 eye, retina UBE3B.b 3569 to 4015 1 to 454     Submitted on the opposite strand 454/457
(99 %)
12 diff
(97.4 %id)
AA843504 parathyroid gland, parathyroid tumor UBE3B.b 3569 to 4132 1 to 564     Submitted on the opposite strand 564/564
(100 %)
1 diff
(99.9 %id)
AA844511 parathyroid gland, parathyroid tumor UBE3B.b 3569 to 4052 1 to 482     Submitted on the opposite strand 482/483
(99 %)
4 diff
(99.2 %id)
AI034041 parathyroid gland, parathyroid tumor UBE3B.b 3569 to 4072 1 to 504     Submitted on the opposite strand 504/504
(100 %)
0 diff
(100 %id)
AI038516   UBE3B.b 3569 to 4072 1 to 506     Submitted on the opposite strand 506/506
(100 %)
6 diff
(98.9 %id)
AI184044 lung UBE3B.b 3569 to 4051 1 to 483     Submitted on the opposite strand 483/483
(100 %)
1 diff
(99.8 %id)
AI473292 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.b 3569 to 3829 1 to 262     Submitted on the opposite strand 262/262
(100 %)
1 diff
(99.7 %id)
AI566129 Kidney UBE3B.b 3569 to 4087 1 to 519     Submitted on the opposite strand 519/519
(100 %)
0 diff
(100 %id)
AI628450 Kidney UBE3B.b 3569 to 4062 1 to 494     Submitted on the opposite strand 494/494
(100 %)
1 diff
(99.8 %id)
AI913742 Kidney UBE3B.b 3569 to 3910 1 to 342     Submitted on the opposite strand 342/342
(100 %)
0 diff
(100 %id)
AI741035 pooled UBE3B.b 3569 to 4067 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
AI760863 B-cell, chronic lymphotic leukemia UBE3B.b 3569 to 4071 1 to 503     Submitted on the opposite strand 503/503
(100 %)
3 diff
(99.5 %id)
AI951603 fibrotheoma, ovary UBE3B.b 3569 to 4128 1 to 560     Submitted on the opposite strand 560/560
(100 %)
0 diff
(100 %id)
BF733011 fibrotheoma, ovary UBE3B.b 3569 to 4121 1 to 554     Submitted on the opposite strand 554/554
(100 %)
1 diff
(99.9 %id)
AA496798   UBE3B.b 3570 to 4039 1 to 468     Submitted on the opposite strand 468/468
(100 %)
4 diff
(99.2 %id)
AA975049 Kidney UBE3B.b 3570 to 4102 1 to 531     Submitted on the opposite strand 531/531
(100 %)
4 diff
(99.3 %id)
AI022477 parathyroid gland, parathyroid tumor UBE3B.b 3570 to 3932 1 to 363   AAA Submitted on the opposite strand 363/363
(100 %)
1 diff
(99.8 %id)
AW136700   UBE3B.b 3570 to 4046 1 to 477     Submitted on the opposite strand 477/477
(100 %)
0 diff
(100 %id)
AW576512 lymph UBE3B.b 3570 to 4036 1 to 467     Submitted on the opposite strand 467/467
(100 %)
0 diff
(100 %id)
BE674825 B-cell, chronic lymphotic leukemia UBE3B.b 3571 to 4127 1 to 557     Submitted on the opposite strand 557/557
(100 %)
0 diff
(100 %id)
R06429 liver and spleen UBE3B.b 3575 to 3937 365 to 1       365/365
(100 %)
10 diff
(97.3 %id)
AA535131 colon UBE3B.b 3576 to 3693 1 to 118     Submitted on the opposite strand 118/118
(100 %)
4 diff
(96.7 %id)
AI078612 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.b 3576 to 3693 1 to 118     Submitted on the opposite strand 118/118
(100 %)
3 diff
(97.5 %id)
AA323742 brain, cerebellum UBE3B.b 3577 to 3729 1 to 153       153/153
(100 %)
0 diff
(100 %id)
AA325073 brain, cerebellum UBE3B.b 3577 to 4105 1 to 530       530/533
(99 %)
8 diff
(98.5 %id)
W90608 liver and spleen UBE3B.b 3578 to 3935 357 to 1   fully sequenced,   357/357
(100 %)
8 diff
(97.8 %id)
AW129379 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE3B.b 3579 to 3736 1 to 158     Submitted on the opposite strand 158/158
(100 %)
1 diff
(99.4 %id)
AI142060 pooled UBE3B.b 3587 to 4070 1 to 484     Submitted on the opposite strand 484/484
(100 %)
0 diff
(100 %id)
AI522191 Kidney UBE3B.b 3587 to 3940 1 to 354     Submitted on the opposite strand 354/354
(100 %)
0 diff
(100 %id)
AI469827 pooled UBE3B.b 3587 to 3952 1 to 366     Submitted on the opposite strand 366/366
(100 %)
1 diff
(99.8 %id)
DA723400   UBE3B.c 1 to 313 2 to 314   tiling clone, capped   313/313
(100 %)
0 diff
(100 %id)
DB115243 thymus UBE3B.c 226 to 764 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AK307385 bladder UBE3B.c 228 to 2990 1 to 2763   tiling clone,   2763/2763
(100 %)
0 diff
(100 %id)
DA039573 bladder UBE3B.c 229 to 792 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
AA307783 colon UBE3B.c 236 to 807 1 to 573       573/574
(99 %)
2 diff
(99.7 %id)
CB960503 Human Placenta, placenta UBE3B.c 2710 to 3441 27 to 766   tiling clone,   738/830
(88 %)
18 diff
(97.9 %id)
BF932875 nervous_tumor UBE3B.c 3003 to 3414 13 to 424       412/424
(97 %)
5 diff
(98.9 %id)
BF933347 nervous_tumor UBE3B.c 3003 to 3414 13 to 424       412/424
(97 %)
5 diff
(98.9 %id)
AK304678 uterus UBE3B.c 3097 to 4514 1 to 1418   tiling clone,   1418/1418
(100 %)
0 diff
(100 %id)
DC422060 uterus UBE3B.c 3097 to 3630 1 to 534       534/534
(100 %)
0 diff
(100 %id)
R83883 liver and spleen UBE3B.c 3120 to 3490 1 to 374       374/374
(100 %)
9 diff
(97.6 %id)
H54107 liver and spleen UBE3B.c 3121 to 3567 1 to 458       458/461
(99 %)
23 diff
(95.1 %id)
AI738606 colon, colon tumor, RER+ UBE3B.c 3296 to 4105 807 to 1       807/838
(96 %)
22 diff
(97.4 %id)
DC347149 tongue, tumor tissue UBE3B.c 3416 to 3951 1 to 536       536/536
(100 %)
0 diff
(100 %id)
DC345573 tongue, tumor tissue UBE3B.c 3418 to 3996 1 to 579       579/579
(100 %)
0 diff
(100 %id)
AI521693 Kidney UBE3B.c 3538 to 3872 335 to 1       335/335
(100 %)
0 diff
(100 %id)
BE675613 B-cell, chronic lymphotic leukemia UBE3B.c 3602 to 4105 504 to 1       504/504
(100 %)
0 diff
(100 %id)
AI239747 pooled UBE3B.c 3618 to 4105 488 to 1       488/488
(100 %)
2 diff
(99.6 %id)
AI382113 pooled UBE3B.c 3634 to 4105 471 to 1       471/471
(100 %)
4 diff
(99.2 %id)
AI524358 Prostate UBE3B.c 3646 to 4105 460 to 1       460/460
(100 %)
0 diff
(100 %id)
AW071764 anaplastic oligodendroglioma, brain UBE3B.c 3648 to 4105 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AW071876 anaplastic oligodendroglioma, brain UBE3B.c 3648 to 4105 458 to 1       458/458
(100 %)
0 diff
(100 %id)
BE795908 lung, small cell carcinoma UBE3B.c 3664 to 4288 1 to 626       626/626
(100 %)
2 diff
(99.7 %id)
AW028322 thymus, pooled UBE3B.c 3668 to 4105 438 to 1       438/438
(100 %)
1 diff
(99.8 %id)
BF059032 fibrotheoma, ovary UBE3B.c 3682 to 4105 424 to 1       424/424
(100 %)
0 diff
(100 %id)
AI928772 anaplastic oligodendroglioma, brain UBE3B.c 3709 to 4096 386 to 1       386/446
(86 %)
7 diff
(98.5 %id)
AA768723 germinal center B cell UBE3B.c 3710 to 4032 324 to 1       324/324
(100 %)
2 diff
(99.4 %id)
AA970103 pooled UBE3B.c 3710 to 4101 392 to 4       389/392
(99 %)
0 diff
(100 %id)
AA769025 germinal center B cell UBE3B.c 3796 to 4017 222 to 1       222/222
(100 %)
4 diff
(98.2 %id)
DA301530 hippocampus UBE3B.c 3801 to 4350 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
AA846230 parathyroid gland, parathyroid tumor UBE3B.c 3808 to 4079 271 to 2       270/271
(99 %)
0 diff
(100 %id)
BF060722 pooled UBE3B.c 3856 to 4105 250 to 1       250/250
(100 %)
0 diff
(100 %id)
CB992225 placenta, pre-eclamptic placenta UBE3B.c 3864 to 4654 27 to 824   tiling clone,   798/824
(96 %)
6 diff
(99.3 %id)
AA721267 germinal center B cell UBE3B.c 3903 to 4040 138 to 1       138/141
(97 %)
1 diff
(99.3 %id)
DB324314   UBE3B.c 3905 to 4464 560 to 1       560/560
(100 %)
1 diff
(99.9 %id)
AA978104 pooled UBE3B.c 3973 to 4071 99 to 1       99/99
(100 %)
0 diff
(100 %id)
R83884 liver and spleen UBE3B.c 4209 to 4463 265 to 10       256/265
(96 %)
0 diff
(100 %id)
DC425975 tongue, tumor tissue UBE3B.c 5591 to 6144 554 to 1   tiling clone,   554/554
(100 %)
4 diff
(99.3 %id)
DB308046 hippocampus UBE3B.c 5597 to 6142 546 to 1   tiling clone,   546/546
(100 %)
0 diff
(100 %id)
AL096740 uterus UBE3B.d 1 to 3760 8 to 3766 exact tiling clone, available from DKFZ,   3766/3766
(100 %)
1 diff
(100.0 %id)
AI262348 adenocarcinoma, colon UBE3B.d 3300 to 3737 438 to 1       438/461
(95 %)
8 diff
(98.3 %id)
AI371389 2 pooled tumors (clear cell type), Kidney UBE3B.d 3300 to 3768 468 to 1       468/479
(97 %)
9 diff
(98.2 %id)
AW440713 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood UBE3B.d 3301 to 3768 468 to 2       467/491
(95 %)
18 diff
(96.4 %id)
TI_149312038   UBE3B.d 3304 to 4127 900 to 88   tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 813/955
(85 %)
13 diff
(98.7 %id)
DA595283 lung UBE3B.d 3323 to 3888 2 to 571   capped   570/570
(100 %)
4 diff
(99.3 %id)
AA160438 Pancreas UBE3B.d 3331 to 3723 1 to 394       394/395
(99 %)
2 diff
(99.5 %id)
BP384239 pancreatic islet UBE3B.d 3347 to 3843 497 to 1       497/499
(99 %)
0 diff
(100 %id)
AA017549 eye, retina UBE3B.d 3761 to 4184 1 to 444     Submitted on the opposite strand 444/444
(100 %)
20 diff
(95.5 %id)
TI_154134316   UBE3B.d 3761 to 4317 61 to 623     Submitted on the opposite strand 563/979
(57 %)
15 diff
(98.5 %id)
TI_157593987   UBE3B.d 3761 to 4385 52 to 678     Submitted on the opposite strand 627/678
(92 %)
6 diff
(99.2 %id)
H28116 brain UBE3B.d 3769 to 4332 1 to 567     Submitted on the opposite strand 567/636
(89 %)
19 diff
(97.1 %id)
AW960949   UBE3B.d 3770 to 4408 1 to 633       633/638
(99 %)
24 diff
(96.3 %id)
W05719 lung UBE3B.d 3773 to 4375 611 to 2     Submitted on the opposite strand 610/612
(99 %)
0 diff
(100 %id)
T95638 liver and spleen UBE3B.d 3784 to 4105 328 to 1       328/337
(97 %)
13 diff
(96.2 %id)
AA448870   UBE3B.d 3788 to 4181 1 to 395     Submitted on the opposite strand 395/395
(100 %)
13 diff
(96.8 %id)
AK056015   UBE3B.d 3800 to 5807 1 to 2009   available from FLJ,   2009/2009
(100 %)
4 diff
(99.9 %id)
AA021187 eye, retina UBE3B.d 3800 to 4154 1 to 361     Submitted on the opposite strand 361/406
(88 %)
10 diff
(97.6 %id)
DA683752   UBE3B.d 3801 to 4326 2 to 527   capped   526/526
(100 %)
0 diff
(100 %id)
H54317.
matches multiple genes
liver and spleen UBE3B.d 3802 to 4122 321 to 1     also hits gene deynaw 321/326
(98 %)
4 diff
(98.8 %id)
BE856909 pooled UBE3B.d 3804 to 4132 1 to 329     Submitted on the opposite strand 329/329
(100 %)
4 diff
(98.8 %id)
R86703 brain UBE3B.d 3808 to 4191 1 to 388     Submitted on the opposite strand 388/393
(98 %)
6 diff
(98.5 %id)
AI038813 senescent fibroblast UBE3B.d 3831 to 4239 1 to 409     Submitted on the opposite strand 409/409
(100 %)
0 diff
(100 %id)
AA766754 germinal center B cell UBE3B.d 3852 to 4278 1 to 425     Submitted on the opposite strand 425/431
(98 %)
7 diff
(98.4 %id)
AA732391 germinal center B cell UBE3B.d 3857 to 4031 1 to 175     Submitted on the opposite strand 175/175
(100 %)
0 diff
(100 %id)
BE789727 large cell carcinoma, lung UBE3B.d 3913 to 4676 4 to 751       748/920
(81 %)
51 diff
(94.5 %id)
W79477 heart UBE3B.d 3935 to 4375 440 to 1     Submitted on the opposite strand 440/440
(100 %)
3 diff
(99.4 %id)
EC451128 Prostate UBE3B.d 3960 to 4059 1 to 97       97/97
(100 %)
2 diff
(98.0 %id)
EC494851 Prostate UBE3B.d 3960 to 4059 1 to 100       100/100
(100 %)
0 diff
(100 %id)
BG987516 head_neck UBE3B.d 3981 to 4348 370 to 1       370/370
(100 %)
0 diff
(100 %id)
BE810861 amnion_normal UBE3B.d 3996 to 4420 12 to 437       426/458
(93 %)
5 diff
(99.0 %id)
BE810799 amnion_normal UBE3B.d 4008 to 4405 33 to 430       398/430
(92 %)
8 diff
(98.2 %id)
BQ291759 amnion_normal UBE3B.d 4009 to 4350 1 to 342       342/342
(100 %)
5 diff
(98.6 %id)
BQ291556 amnion_normal UBE3B.d 4021 to 4369 29 to 385       357/385
(92 %)
6 diff
(98.5 %id)
BE810837 amnion_normal UBE3B.d 4028 to 4406 380 to 3       378/380
(99 %)
0 diff
(100 %id)
BE810800 amnion_normal UBE3B.d 4029 to 4357 336 to 7       330/336
(98 %)
0 diff
(100 %id)
BE810796 amnion_normal UBE3B.d 4039 to 4420 1 to 386       386/386
(100 %)
14 diff
(96.4 %id)
TI_2194697096   UBE3B.d 4041 to 4677 12 to 648       637/1244
(51 %)
1 diff
(100.0 %id)
BE810835 amnion_normal UBE3B.d 4055 to 4420 374 to 9       366/374
(97 %)
0 diff
(100 %id)
BQ334839 marrow UBE3B.d 4088 to 4415 1 to 331       331/331
(100 %)
18 diff
(94.6 %id)
CR613548 fetal brain UBE3B.d 4104 to 5762 1 to 1659       1659/1659
(100 %)
0 diff
(100 %id)
AL537608 brain, fetal brain UBE3B.d 4104 to 5060 1 to 958       958/958
(100 %)
2 diff
(99.8 %id)
CR616108 fetal liver UBE3B.d 4106 to 5779 1 to 1674   tiling clone,   1674/1674
(100 %)
0 diff
(100 %id)
BX406094 fetal liver, Liver UBE3B.d 4106 to 5025 1 to 907   fully sequenced,   907/907
(100 %)
13 diff
(98.6 %id)
N80470 liver and spleen UBE3B.d 4146 to 4648 1 to 520       520/520
(100 %)
27 diff
(94.9 %id)
W21104 lung UBE3B.d 4155 to 4355 1 to 201       201/204
(98 %)
5 diff
(97.6 %id)
BQ291558 amnion_normal UBE3B.d 4172 to 4538 414 to 44       371/414
(89 %)
0 diff
(100 %id)
BF905640 marrow UBE3B.d 4233 to 4588 361 to 7     Submitted on the opposite strand 355/361
(98 %)
0 diff
(100 %id)
R95487   UBE3B.d 4238 to 4392 1 to 155       155/155
(100 %)
0 diff
(100 %id)
BG008045 placenta_normal UBE3B.d 4273 to 4632 6 to 367       362/367
(98 %)
6 diff
(98.4 %id)
BC013182 Adrenal cortex, carcinoma UBE3B.d 4284 to 5805 1 to 1519   available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 1519/1519
(100 %)
4 diff
(99.8 %id)
BF792492 adrenal cortex carcinoma, cell line, adrenal gland UBE3B.d 4284 to 4937 1 to 649   available from MGC,   649/649
(100 %)
8 diff
(98.8 %id)
BQ344942 nervous_tumor UBE3B.d 4306 to 4440 135 to 1       135/135
(100 %)
9 diff
(93.4 %id)
BU956664 adenocarcinoma, cell line, breast UBE3B.d 4355 to 5173 1 to 832       832/905
(91 %)
20 diff
(97.8 %id)
BX500458 Liver UBE3B.d 4366 to 4912 139 to 685       646/688
(93 %)
17 diff
(97.6 %id)
TI_2194697103   UBE3B.d 4368 to 4677 8 to 316       309/1267
(24 %)
5 diff
(99.7 %id)
TI_2016725637   UBE3B.d 4372 to 4685 12 to 323       312/1257
(24 %)
6 diff
(99.6 %id)
BQ889238 dorsal root ganglia UBE3B.d 4380 to 5265 1 to 896       896/901
(99 %)
18 diff
(98.1 %id)
D78671 placenta UBE3B.d 4396 to 4912 1 to 514       514/520
(98 %)
9 diff
(98.3 %id)
EB388830 eye, optic nerve UBE3B.d 4617 to 5308 102 to 794       693/794
(87 %)
6 diff
(99.3 %id)
BG002321 placenta_normal UBE3B.d 4624 to 4856 1 to 231       231/231
(100 %)
5 diff
(97.9 %id)
TI_151798285   UBE3B.d 4630 to 5135 101 to 610       510/806
(63 %)
22 diff
(97.3 %id)
AA312078   UBE3B.d 4657 to 5064 1 to 408       408/408
(100 %)
0 diff
(100 %id)
BF849616 lung_normal UBE3B.d 4711 to 5020 12 to 322       311/322
(96 %)
6 diff
(98.2 %id)
BP429097   UBE3B.d 4723 to 5108 1 to 386       386/386
(100 %)
3 diff
(99.3 %id)
BG682243 skin, squamous cell carcinoma UBE3B.d 4784 to 5584 1 to 800       800/801
(99 %)
10 diff
(98.8 %id)
AL566899 brain, fetal brain UBE3B.d 4803 to 5762 954 to 1       954/963
(99 %)
16 diff
(98.4 %id)
BF670765 muscle (skeletal) UBE3B.d 4837 to 5479 1 to 639       639/892
(71 %)
21 diff
(97.7 %id)
BX451603 brain, fetal brain UBE3B.d 4904 to 5806 1 to 901       901/901
(100 %)
7 diff
(99.3 %id)
TI_149307003   UBE3B.d 4912 to 5706 64 to 857     Submitted on the opposite strand 794/1046
(75 %)
19 diff
(98.2 %id)
BM704645 eye, RPE and Choroid UBE3B.d 4914 to 5515 9 to 610       602/610
(98 %)
6 diff
(99.1 %id)
TI_151766243   UBE3B.d 4915 to 5296 112 to 487       376/472
(79 %)
6 diff
(98.8 %id)
BM978942 lung, Primary Lung Epithelial Cells UBE3B.d 4918 to 5516 1 to 598     Submitted on the opposite strand 598/598
(100 %)
3 diff
(99.5 %id)
CB241483 Human Lung Epithelial cells, lung UBE3B.d 4918 to 5703 1 to 786     Submitted on the opposite strand 786/795
(98 %)
3 diff
(99.7 %id)
T25154   UBE3B.d 4927 to 5014 1 to 88       88/92
(95 %)
1 diff
(99.0 %id)
AA235108 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.d 4930 to 5357 1 to 429     Submitted on the opposite strand 429/429
(100 %)
3 diff
(99.4 %id)
CD107179 brain, Pituitary UBE3B.d 4970 to 5763 1 to 799       799/813
(98 %)
16 diff
(98.1 %id)
BM759724 stomach UBE3B.d 4977 to 5525 1 to 551       551/551
(100 %)
2 diff
(99.7 %id)
W00590 lung UBE3B.d 4989 to 5454 1 to 457       457/457
(100 %)
10 diff
(97.9 %id)
BX406093 fetal liver, Liver UBE3B.d 4995 to 5779 774 to 1   fully sequenced,   774/774
(100 %)
8 diff
(99.0 %id)
H30674 brain UBE3B.d 5016 to 5491 485 to 3     Submitted on the opposite strand 483/495
(97 %)
0 diff
(100 %id)
T12414   UBE3B.d 5040 to 5434 1 to 392       392/392
(100 %)
9 diff
(97.8 %id)
TI_151705631   UBE3B.d 5052 to 5808 831 to 84       748/1004
(74 %)
0 diff
(100 %id)
DR760197 embryonic stem UBE3B.d 5061 to 5811 757 to 7   tiling clone, Submitted on the opposite strand 751/757
(99 %)
0 diff
(100 %id)
CA431777 Bone, Subchondral Bone UBE3B.d 5083 to 5807 743 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 725/725
(100 %)
0 diff
(100 %id)
AA384068 thyroid gland UBE3B.d 5084 to 5396 1 to 315       315/315
(100 %)
3 diff
(99.1 %id)
CX763133 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE3B.d 5086 to 5807 745 to 32   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 714/783
(91 %)
14 diff
(98.3 %id)
AA482520 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.d 5089 to 5437 1 to 350       350/350
(100 %)
4 diff
(98.9 %id)
BX330207 Placenta Cot 25-normalized UBE3B.d 5102 to 5772 682 to 13       670/797
(84 %)
0 diff
(100 %id)
AA325367 brain, cerebellum UBE3B.d 5154 to 5542 1 to 401       401/454
(88 %)
15 diff
(96.7 %id)
TI_154154138   UBE3B.d 5154 to 5806 736 to 85     Submitted on the opposite strand 652/657
(99 %)
0 diff
(100 %id)
AW955325   UBE3B.d 5155 to 5703 1 to 549       549/549
(100 %)
6 diff
(99.0 %id)
CX751460 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass UBE3B.d 5159 to 5808 701 to 53       649/701
(92 %)
0 diff
(100 %id)
BU156799 leiomyosarcoma, uterus UBE3B.d 5169 to 5805 1 to 637   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 637/637
(100 %)
5 diff
(99.3 %id)
W78959 liver and spleen UBE3B.d 5188 to 5481 1 to 300   fully sequenced,   300/300
(100 %)
4 diff
(98.7 %id)
AW517234 cervix UBE3B.d 5201 to 5665 467 to 3       465/467
(99 %)
0 diff
(100 %id)
BG493515 lung, mucoepidermoid carcinoma UBE3B.d 5215 to 5567 1 to 362       362/512
(70 %)
14 diff
(97.3 %id)
BG493522 lung, mucoepidermoid carcinoma UBE3B.d 5215 to 5727 1 to 522       522/793
(65 %)
11 diff
(98.7 %id)
BG527820 lung, mucoepidermoid carcinoma UBE3B.d 5215 to 5772 1 to 555       555/555
(100 %)
2 diff
(99.7 %id)
AI749193 colon UBE3B.d 5266 to 5808 544 to 5       540/544
(99 %)
0 diff
(100 %id)
TI_154160018   UBE3B.d 5269 to 5805 639 to 106   AAA Submitted on the opposite strand 534/534
(100 %)
3 diff
(99.5 %id)
AW500012 lymph UBE3B.d 5275 to 5806 544 to 13     Submitted on the opposite strand 532/544
(97 %)
0 diff
(100 %id)
BQ003268 Chondrosarcoma, Left Pelvis UBE3B.d 5276 to 5807 545 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 529/529
(100 %)
3 diff
(99.5 %id)
DB322801   UBE3B.d 5289 to 5807 519 to 1       519/519
(100 %)
1 diff
(99.9 %id)
BP387624 pancreatic islet UBE3B.d 5290 to 5806 1 to 517     Submitted on the opposite strand 517/520
(99 %)
4 diff
(99.3 %id)
BM709721 eye, Retina Foveal and Macular UBE3B.d 5290 to 5807 1 to 518       518/518
(100 %)
0 diff
(100 %id)
BP391763 pancreatic islet UBE3B.d 5308 to 5805 1 to 498     Submitted on the opposite strand 498/498
(100 %)
0 diff
(100 %id)
BF955349 nervous_normal UBE3B.d 5312 to 5639 391 to 64       328/391
(83 %)
0 diff
(100 %id)
AW503974 lymph UBE3B.d 5312 to 5805 518 to 28   AAA Submitted on the opposite strand 491/491
(100 %)
2 diff
(99.6 %id)
BQ023807 placenta UBE3B.d 5314 to 5805 510 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 492/502
(98 %)
2 diff
(99.7 %id)
AI769223 pooled UBE3B.d 5315 to 5808 499 to 8       492/499
(98 %)
0 diff
(100 %id)
AI720354 colon UBE3B.d 5316 to 5801 486 to 1       486/486
(100 %)
0 diff
(100 %id)
BF589175 pooled UBE3B.d 5326 to 5806 481 to 4       478/481
(99 %)
0 diff
(100 %id)
AW058126 thymus, pooled UBE3B.d 5332 to 5808 481 to 8       474/481
(98 %)
0 diff
(100 %id)
BF515214   UBE3B.d 5336 to 5664 342 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 329/343
(95 %)
4 diff
(98.9 %id)
BM666185 eye, fetal eyes UBE3B.d 5337 to 5807 487 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
BM693164 eye, Retina Foveal and Macular UBE3B.d 5341 to 5479 1 to 139   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 139/139
(100 %)
1 diff
(99.3 %id)
AI371974 pooled germ cell tumors UBE3B.d 5350 to 5805 473 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 456/456
(100 %)
0 diff
(100 %id)
AW021415 cochlea, ear UBE3B.d 5353 to 5807 1 to 452   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 452/452
(100 %)
6 diff
(98.7 %id)
AA017421 eye, retina UBE3B.d 5360 to 5806 449 to 6     Submitted on the opposite strand 444/449
(98 %)
0 diff
(100 %id)
AI027749   UBE3B.d 5364 to 5808 448 to 4       445/448
(99 %)
0 diff
(100 %id)
BP398813 pancreatic islet UBE3B.d 5373 to 5805 1 to 433     Submitted on the opposite strand 433/433
(100 %)
3 diff
(99.4 %id)
R55450 breast UBE3B.d 5377 to 5782 1 to 419       419/420
(99 %)
20 diff
(95.3 %id)
N63625 liver and spleen UBE3B.d 5377 to 5806 430 to 4       427/430
(99 %)
0 diff
(100 %id)
AA601599 breast UBE3B.d 5377 to 5796 421 to 4       418/421
(99 %)
0 diff
(100 %id)
AA235217 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.d 5383 to 5806 427 to 1     Submitted on the opposite strand 427/427
(100 %)
5 diff
(98.9 %id)
AI075880   UBE3B.d 5386 to 5807 434 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 419/419
(100 %)
5 diff
(98.9 %id)
AI492264 brain, glioblastoma (pooled) UBE3B.d 5386 to 5805 444 to 25   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 420/420
(100 %)
2 diff
(99.6 %id)
AA015723 eye, retina UBE3B.d 5387 to 5808 423 to 3     Submitted on the opposite strand 421/426
(98 %)
0 diff
(100 %id)
AI056860 liver and spleen UBE3B.d 5390 to 5805 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
BG942075 blood UBE3B.d 5392 to 5806 441 to 30       412/441
(93 %)
0 diff
(100 %id)
AW444749   UBE3B.d 5392 to 5807 431 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 416/416
(100 %)
3 diff
(99.3 %id)
BF222664 Prostate UBE3B.d 5395 to 5808 412 to 2       411/412
(99 %)
0 diff
(100 %id)
AI684298 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE3B.d 5403 to 5808 406 to 1       406/406
(100 %)
2 diff
(99.6 %id)
AI826258 normal prostate, Prostate UBE3B.d 5437 to 5807 394 to 24   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 371/371
(100 %)
7 diff
(98.2 %id)
BU957832 mixed (pool of 40 RNAs) UBE3B.d 5445 to 5808 1 to 364       364/399
(91 %)
2 diff
(99.5 %id)
BM668391 eye, Retina Foveal and Macular UBE3B.d 5449 to 5805 374 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 356/356
(100 %)
5 diff
(98.6 %id)
W80453 liver and spleen UBE3B.d 5451 to 5807 358 to 1   fully sequenced,   358/358
(100 %)
6 diff
(98.4 %id)
EC581346 Prostate UBE3B.d 5457 to 5556 7 to 106       100/108
(92 %)
1 diff
(99.1 %id)
AA055649 colon, tumor UBE3B.d 5462 to 5808 347 to 1       347/347
(100 %)
0 diff
(100 %id)
AA159479 Pancreas UBE3B.d 5462 to 5808 349 to 6       344/349
(98 %)
0 diff
(100 %id)
AA533567 ovary UBE3B.d 5462 to 5806 349 to 8       342/349
(97 %)
0 diff
(100 %id)
AA558483 germ cell tumor UBE3B.d 5462 to 5805 363 to 20   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 344/344
(100 %)
0 diff
(100 %id)
AA021285 eye, retina UBE3B.d 5478 to 5796 323 to 1     Submitted on the opposite strand 323/351
(92 %)
11 diff
(96.9 %id)
AA417823 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.d 5499 to 5805 304 to 1       304/304
(100 %)
1 diff
(99.7 %id)
AA069759   UBE3B.d 5502 to 5811 1 to 310       310/310
(100 %)
1 diff
(99.7 %id)
BE247112 leukopheresis UBE3B.d 5516 to 5807 289 to 1       289/289
(100 %)
4 diff
(98.7 %id)
AA057021 eye, retina UBE3B.d 5519 to 5807 289 to 1     Submitted on the opposite strand 289/292
(98 %)
4 diff
(98.7 %id)
AA486633 lung UBE3B.d 5527 to 5808 1 to 282   fully sequenced,   282/282
(100 %)
0 diff
(100 %id)
N68913 lung UBE3B.d 5529 to 5807 281 to 1       281/282
(99 %)
4 diff
(98.6 %id)
N93443 lung UBE3B.d 5644 to 5805 162 to 1       162/162
(100 %)
0 diff
(100 %id)
T12413   UBE3B.d 5651 to 5806 158 to 3       156/158
(98 %)
0 diff
(100 %id)
AA486538 lung UBE3B.d 5663 to 5806 144 to 1   fully sequenced,   144/144
(100 %)
0 diff
(100 %id)
DA110939 cerebellum UBE3B.e 1 to 523 2 to 523   tiling clone, capped   522/529
(98 %)
4 diff
(99.3 %id)
AK127227 hippocampus UBE3B.e 122 to 4649 1 to 4523 exact tiling clone, available from FLJ,   4523/4523
(100 %)
9 diff
(99.9 %id)
DA313557 hippocampus UBE3B.e 123 to 651 2 to 531   capped   530/530
(100 %)
3 diff
(99.5 %id)
AA705878 liver and spleen UBE3B.e 188 to 521 387 to 57   tiling clone,   331/387
(85 %)
0 diff
(100 %id)
DA336988 hippocampus UBE3B.e 509 to 1095 2 to 588   tiling clone, capped   587/587
(100 %)
0 diff
(100 %id)
AV689725 hepatocellular carcinoma UBE3B.e 601 to 977 373 to 4     Submitted on the opposite strand 370/373
(99 %)
0 diff
(100 %id)
DA097857 cerebellum UBE3B.e 767 to 1333 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DB308623 hippocampus UBE3B.e 4079 to 4649 568 to 1       568/568
(100 %)
2 diff
(99.7 %id)
DB309933 hippocampus UBE3B.e 4124 to 4647 524 to 1   tiling clone,   524/524
(100 %)
1 diff
(99.9 %id)
DA936916 Spleen UBE3B.f 1 to 553 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
BM792096 Ascites, stomach UBE3B.f 386 to 1056 1 to 671   tiling clone,   671/671
(100 %)
0 diff
(100 %id)
W60127 heart UBE3B.f 409 to 859 1 to 454       454/462
(98 %)
11 diff
(97.7 %id)
R48525 breast UBE3B.f 427 to 770 1 to 348       348/348
(100 %)
6 diff
(98.3 %id)
W60030 heart UBE3B.f 1103 to 1541 446 to 4   tiling clone,   443/473
(93 %)
7 diff
(98.6 %id)
R48526 breast UBE3B.f 1116 to 1521 428 to 18   tiling clone,   411/428
(96 %)
11 diff
(97.5 %id)
BE241777 leukopheresis UBE3B.g 1 to 363 363 to 1   tiling clone,   363/363
(100 %)
3 diff
(99.2 %id)
BM193869 leukopheresis UBE3B.g 55 to 363 309 to 1   tiling clone,   309/328
(94 %)
0 diff
(100 %id)
AK301036 Spleen UBE3B.g 303 to 1532 1 to 1230   tiling clone,   1230/1230
(100 %)
0 diff
(100 %id)
DC389072 Spleen UBE3B.g 303 to 864 1 to 562       562/562
(100 %)
0 diff
(100 %id)
AA028989 uterus UBE3B.g 657 to 1151 10 to 505   fully sequenced,   496/505
(98 %)
5 diff
(99.1 %id)
DC376476 brain UBE3B.g 809 to 1360 1 to 554       554/554
(100 %)
2 diff
(99.7 %id)
AA030006 uterus UBE3B.g 1149 to 1656 511 to 1   tiling clone, fully sequenced,   511/511
(100 %)
11 diff
(97.9 %id)
DC426624 Spleen UBE3B.g 3169 to 3698 530 to 1   tiling clone,   530/530
(100 %)
0 diff
(100 %id)
CR601612 neuroblastoma UBE3B.h 1 to 1468 1 to 1468 exact tiling clone,   1468/1468
(100 %)
0 diff
(100 %id)
AL518801 brain, neuroblastoma, neuroblastoma cells UBE3B.h 1 to 715 1 to 714   fully sequenced,   714/714
(100 %)
7 diff
(99.1 %id)
BX394038 Neuroblastoma Cot 25-normalized UBE3B.h 229 to 1325 1 to 1084 exact     1084/1130
(95 %)
19 diff
(98.4 %id)
CR614569 T cells (Jurkat cell line) Cot10-normalized UBE3B.h 238 to 1463 1 to 1226 exact     1226/1226
(100 %)
0 diff
(100 %id)
BX362106   UBE3B.h 238 to 715 1 to 478   fully sequenced,   478/478
(100 %)
1 diff
(99.8 %id)
AL561748 brain, neuroblastoma, neuroblastoma cells UBE3B.h 654 to 1468 815 to 1   fully sequenced,   815/815
(100 %)
20 diff
(97.6 %id)
BX362105   UBE3B.h 654 to 1459 809 to 4   fully sequenced,   806/809
(99 %)
1 diff
(99.9 %id)
DB099012 testis UBE3B.i 1 to 590 2 to 592   tiling clone, capped   591/591
(100 %)
1 diff
(99.9 %id)
BM049606 carcinoma, cell line, Prostate UBE3B.i 14 to 853 1 to 841       839/841
(99 %)
13 diff
(98.5 %id)
BC068221 Prostate, carcinoma UBE3B.i 15 to 1038 1 to 1024 exact tiling clone, available from MGC, AAA   1024/1024
(100 %)
0 diff
(100 %id)
BU541781 carcinoma, cell line, Prostate UBE3B.i 15 to 889 26 to 912   available from MGC,   885/939
(94 %)
26 diff
(97.3 %id)
BQ928951 carcinoma, cell line, Prostate UBE3B.i 16 to 965 1 to 949       949/951
(99 %)
14 diff
(98.6 %id)
BC051266 Skin, melanotic melanoma. UBE3B.j 1 to 1446 1 to 1446 exact tiling clone, available from MGC, AAA   1446/1446
(100 %)
0 diff
(100 %id)
R10969 liver and spleen UBE3B.j 2 to 132 1 to 130       130/130
(100 %)
2 diff
(98.5 %id)
AA481986 ovarian tumor, ovary UBE3B.j 142 to 639 1 to 498       498/501
(99 %)
1 diff
(99.9 %id)
CR600136 Neuroblastoma Cot 25-normalized UBE3B.j 323 to 1380 1 to 1058 exact     1058/1058
(100 %)
0 diff
(100 %id)
AA482088 ovarian tumor, ovary UBE3B.j 800 to 1360 561 to 1       561/561
(100 %)
5 diff
(99.2 %id)
R10916 liver and spleen UBE3B.j 1041 to 1351 310 to 1       310/312
(99 %)
2 diff
(99.4 %id)
BC108705 Lung, large cell carcinoma UBE3B.k 1 to 1106 1 to 1106 exact tiling clone, AAA   1106/1106
(100 %)
0 diff
(100 %id)
BQ436381 large cell carcinoma, lung UBE3B.k 7 to 1043 1 to 1031 I177N R186S P187T N190K N201X ...     1031/1034
(99 %)
25 diff
(97.6 %id)
H63472 liver and spleen UBE3B.k 8 to 519 1 to 509       509/510
(99 %)
22 diff
(95.7 %id)
AA002220 liver and spleen UBE3B.k 8 to 494 1 to 487       487/487
(100 %)
6 diff
(98.8 %id)
AA478844 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.k 163 to 484 15 to 335       321/335
(95 %)
8 diff
(97.7 %id)
BC040155 Bone, osteosarcoma UBE3B.k 187 to 1018 15 to 846 exact available from MGC, AAA   832/832
(100 %)
0 diff
(100 %id)
TI_149299637   UBE3B.k 216 to 1025 912 to 113 F2P T3F L4S S5D Q6L ...     800/1064
(75 %)
13 diff
(98.8 %id)
BX354626 Neuroblastoma Cot 25-normalized UBE3B.k 221 to 510 104 to 393       290/393
(73 %)
7 diff
(98.3 %id)
TI_1948233085   UBE3B.k 245 to 556 135 to 446   fully sequenced,   312/340
(91 %)
6 diff
(98.3 %id)
BU618873 Cell Line, Chondrosarcoma UBE3B.k 272 to 1023 762 to 12   AAA   751/751
(100 %)
5 diff
(99.4 %id)
BE856776 pooled UBE3B.k 285 to 1020 739 to 1       739/739
(100 %)
13 diff
(98.3 %id)
BU634118 cell lines, Chondrosarcoma UBE3B.k 319 to 1023 717 to 14   AAA   704/704
(100 %)
4 diff
(99.5 %id)
BM975943 lung, Primary Lung Cystic Fibrosis EpithelialCells UBE3B.k 354 to 1023 683 to 14   AAA   670/670
(100 %)
4 diff
(99.5 %id)
BE792612 lung, small cell carcinoma UBE3B.k 398 to 1035 1 to 638       638/638
(100 %)
0 diff
(100 %id)
BM931238 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE3B.k 412 to 723 1 to 312   fully sequenced,   312/312
(100 %)
0 diff
(100 %id)
R82783 placenta UBE3B.k 456 to 723 1 to 273   fully sequenced,   273/273
(100 %)
0 diff
(100 %id)
AI928487 Kidney UBE3B.k 456 to 1024 568 to 1       568/568
(100 %)
1 diff
(99.9 %id)
AA452227   UBE3B.k 465 to 1024 1 to 560       560/560
(100 %)
0 diff
(100 %id)
AI675154 anaplastic oligodendroglioma, brain UBE3B.k 499 to 1024 526 to 1       526/526
(100 %)
0 diff
(100 %id)
AI394278 B-cell, chronic lymphotic leukemia UBE3B.k 500 to 1023 537 to 14   AAA   524/524
(100 %)
0 diff
(100 %id)
CA423702 cell lines, Chondrosarcoma UBE3B.k 503 to 1106 621 to 17   AAA   603/605
(99 %)
3 diff
(99.6 %id)
TI_1948233086   UBE3B.k 526 to 978 578 to 126   fully sequenced,   453/578
(78 %)
8 diff
(98.7 %id)
BX372812 Neuroblastoma Cot 25-normalized UBE3B.k 531 to 1022 524 to 32       493/868
(56 %)
12 diff
(98.7 %id)
AW139920   UBE3B.k 581 to 1023 454 to 13   AAA   442/447
(98 %)
5 diff
(98.9 %id)
TI_153991478   UBE3B.k 590 to 1023 528 to 93   AAA   434/436
(99 %)
18 diff
(95.9 %id)
AI347851 2 pooled tumors (clear cell type), Kidney UBE3B.k 592 to 1025 435 to 2       434/435
(99 %)
0 diff
(100 %id)
H63416 liver and spleen UBE3B.k 597 to 1023 430 to 1       430/431
(99 %)
11 diff
(97.5 %id)
AA002093 liver and spleen UBE3B.k 615 to 1038 434 to 1       434/441
(98 %)
14 diff
(96.9 %id)
AI870992 anaplastic oligodendroglioma, brain UBE3B.k 624 to 1024 401 to 1       401/401
(100 %)
8 diff
(98.1 %id)
AI039477   UBE3B.k 636 to 1025 394 to 5       390/394
(98 %)
3 diff
(99.3 %id)
AA479940 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.k 637 to 1044 409 to 1       409/409
(100 %)
2 diff
(99.6 %id)
AI091053 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.k 653 to 1044 392 to 1       392/392
(100 %)
0 diff
(100 %id)
H00628 placenta UBE3B.k 662 to 1009 354 to 1   fully sequenced,   354/354
(100 %)
7 diff
(98.1 %id)
BU743087 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE3B.k 662 to 1023 375 to 14   fully sequenced, AAA   362/362
(100 %)
0 diff
(100 %id)
AA642892 epithelium (cell line), Prostate UBE3B.k 673 to 1105 433 to 1       433/433
(100 %)
0 diff
(100 %id)
AA399509   UBE3B.k 680 to 1025 1 to 346   fully sequenced,   346/346
(100 %)
6 diff
(98.3 %id)
BU615241 Bone, Human Chondrosarcoma Cell Line UBE3B.k 704 to 1106 419 to 17   AAA   403/403
(100 %)
0 diff
(100 %id)
AA398368   UBE3B.k 759 to 1023 265 to 1   fully sequenced,   265/265
(100 %)
0 diff
(100 %id)
AI864528 anaplastic oligodendroglioma, brain UBE3B.k 772 to 1024 254 to 1       254/254
(100 %)
2 diff
(99.3 %id)
AW207298   UBE3B.k 815 to 1023 221 to 13   AAA   209/209
(100 %)
0 diff
(100 %id)
AA644394 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus UBE3B.k 825 to 1044 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AA812485   UBE3B.k 839 to 1027 192 to 4       189/192
(98 %)
0 diff
(100 %id)
AI758130 Kidney UBE3B.k 847 to 1106 260 to 1       260/260
(100 %)
1 diff
(99.7 %id)
GD145510   UBE3B.k 961 to 1025 1 to 65       65/79
(82 %)
1 diff
(98.8 %id)
AI676034 Prostate UBE3B.l 1 to 499 499 to 1 S119X tiling clone,   499/499
(100 %)
0 diff
(100 %id)
AI682476 Prostate UBE3B.l 21 to 499 478 to 1       478/484
(98 %)
4 diff
(99.2 %id)
AA523934 colon UBE3B.m 1 to 650 650 to -4 R7K P12H L16* tiling clone,   650/682
(95 %)
18 diff
(97.4 %id)
BF529297 anaplastic oligodendroglioma with 1p/19qloss, brain UBE3B.n 1 to 719 1 to 719 exact tiling clone,   719/719
(100 %)
3 diff
(99.6 %id)
AW025870 thymus, pooled UBE3B.o 1 to 611 617 to -1 D5N F8I A9C S10I F12L ... tiling clone,   617/661
(93 %)
13 diff
(98.1 %id)
DA582154 lung UBE3B.p-u 1 to 557 2 to 559   tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
DA418300 thalamus UBE3B.p-u 271 to 832 2 to 564 Y120L G121R A122S L123S C124V ... tiling clone, capped   563/563
(100 %)
1 diff
(99.9 %id)
DB232476 trachea UBE3B.q 1 to 585 2 to 587 R21X P23T P24S A25G N26E ... tiling clone, capped   586/586
(100 %)
2 diff
(99.7 %id)
BE772281 prostate_tumor UBE3B.r 1 to 382 382 to 1 exact tiling clone,   382/382
(100 %)
5 diff
(98.7 %id)
BE819220 breast_normal UBE3B.r 82 to 374 307 to 15   tiling clone,   293/307
(95 %)
1 diff
(99.7 %id)
AI693749 pooled UBE3B.s 1 to 516 516 to 1 G46R tiling clone,   516/516
(100 %)
1 diff
(99.9 %id)
AW118987 pooled UBE3B.s 77 to 516 440 to 1 exact tiling clone,   440/440
(100 %)
0 diff
(100 %id)
AW663588 pooled UBE3B.s 151 to 516 366 to 1 exact     366/366
(100 %)
1 diff
(99.8 %id)
AK022019 whole embryo, mainly body UBE3B.t-u 1 to 2406 2 to 2407 exact tiling clone, available from FLJ,   2407/2407
(100 %)
5 diff
(99.8 %id)
AU120548 whole embryo, mainly body UBE3B.t-u 1 to 818 2 to 817   capped   816/816
(100 %)
10 diff
(98.8 %id)
AW073935 2 pooled high-grade transitional celltumors, genitourinary tract UBE3B.t-u 694 to 1062 370 to 1 F10V F12L L13S S14L L15V ...     370/370
(100 %)
1 diff
(99.8 %id)
BQ710796 Spleen UBE3B.t-u 1553 to 2399 12 to 868   tiling clone, AAA   857/877
(97 %)
26 diff
(97.1 %id)
AU146587 whole embryo, mainly body UBE3B.t-u 1885 to 2406 523 to 1       523/523
(100 %)
12 diff
(97.8 %id)
AW439861 serous papillary carcinoma, high grade, 2pooled tumors, uterus UBE3B.t-u 2044 to 2416 373 to 1   tiling clone,   373/373
(100 %)
2 diff
(99.5 %id)
AI871371 anaplastic oligodendroglioma, brain UBE3B.t-u 2052 to 2426 374 to 1   tiling clone,   374/374
(100 %)
36 diff
(90.4 %id)
CA777823 Pancreas, Purified pancreatic islet UBE3B.u 1 to 309 8 to 316   tiling clone, to resequence,   309/316
(97 %)
7 diff
(97.8 %id)
DA232667 brain UBE3B.u 64 to 624 2 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
CA777551 Pancreas, Purified pancreatic islet UBE3B.u 1452 to 1654 203 to 1   tiling clone, to resequence,   203/208
(97 %)
5 diff
(97.6 %id)
BM676408 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE3B.va-u 1 to 641 654 to 14 L9C L10F P11L G12A V14F ... tiling clone, AAA   641/641
(100 %)
2 diff
(99.7 %id)
BU738799 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE3B.va-u 489 to 641 166 to 14   AAA   153/153
(100 %)
0 diff
(100 %id)
BM713293 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid UBE3B.vb-u 1 to 482 1 to 482 exact tiling clone,   482/482
(100 %)
1 diff
(99.8 %id)
TI_2194697097   Gene UBE3B, variant not shown         Suspected internal deletion, this clone was ignored    
TI_2194697100   Gene UBE3B, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
BI004364 head_normal Gene UBE3B, variant not shown              
DB299913 cerebellum Gene UBE3B, variant not shown         This clone was ignored    
DA111689 cerebellum Gene UBE3B, variant not shown       capped This clone was ignored    
DB312512 thalamus Gene UBE3B, variant not shown              
DA409231 thalamus Gene UBE3B, variant not shown       capped      
CD703941 normal nasopharynx Gene UBE3B, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
EL954880 eyeball Gene UBE3B, variant not shown       AAA      
N70000 liver and spleen Gene UBE3B, variant not shown       fully sequenced, AAA      
W00862 liver and spleen Gene UBE3B, variant not shown       fully sequenced,      
AA703018 liver and spleen Gene UBE3B, variant not shown         This clone was ignored    
AA677169 liver and spleen Gene UBE3B, variant not shown         This clone was ignored    
AA779958 liver and spleen Gene UBE3B, variant not shown       AAA This clone was ignored    
AI202717 Prostate Gene UBE3B, variant not shown              
AI992031 anaplastic oligodendroglioma, brain Gene UBE3B, variant not shown              
AW589568 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus Gene UBE3B, variant not shown         Suspected internal deletion, this clone was ignored    
DB000777 breast, tumor tissue Gene UBE3B, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
DB093802 testis Gene UBE3B, variant not shown       capped      
DB097352 testis Gene UBE3B, variant not shown       capped Suspected internal deletion, this clone was ignored    
DB134796 thymus Gene UBE3B, variant not shown       capped      
DB344896 thymus Gene UBE3B, variant not shown              
DB237260 trachea Gene UBE3B, variant not shown       capped      
DB350381 trachea Gene UBE3B, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p-u, .q, .r, .s, .t-u, .u, .va-u, .vb-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC